HomeBiotech

Biotech

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

September 21, 2023

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

September 21, 2023

DRIVING PRECISION MEDICINE FORWARD: BIO-IT WORLD EUROPE CONVENES IN LONDON 29-30 NOVEMBER 2023

DRIVING PRECISION MEDICINE FORWARD: BIO-IT WORLD EUROPE CONVENES IN LONDON 29-30 NOVEMBER 2023

September 21, 2023

Two Cases of Pancreatic Cancer Treatment with CARsgen’s CT041 Published in Journal of Hematology & Oncology

Two Cases of Pancreatic Cancer Treatment with CARsgen’s CT041 Published in Journal of Hematology & Oncology

September 21, 2023

Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011

Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011

September 21, 2023

Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Potential Approvals and Market Launches Expected During the Course of 2024

Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Potential Approvals and Market Launches Expected During the Course of 2024

September 20, 2023

Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis

Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis

September 20, 2023

Vial to Sponsor the 4th Annual Gene Therapy for Ophthalmic Disorders Conference 2023 in Boston, MA

Vial to Sponsor the 4th Annual Gene Therapy for Ophthalmic Disorders Conference 2023 in Boston, MA

September 20, 2023

Strategic Collaborations and Innovations Fuel Global Primary Cell Culture Market; North America Takes the Lead with 41.52% Market Share

Strategic Collaborations and Innovations Fuel Global Primary Cell Culture Market; North America Takes the Lead with 41.52% Market Share

September 20, 2023

CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems

CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems

September 19, 2023

1 2 3 … 48 »